YWHAE Antikörper (C-Term)
-
- Target Alle YWHAE Antikörper anzeigen
- YWHAE (14-3-3 epsilon (YWHAE))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser YWHAE Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Human, Maus, Ratte
- Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from the C-terminal region of Human 14-3-3 epsilon.
- Isotyp
- IgG
- Top Product
- Discover our top product YWHAE Primärantikörper
-
-
- Applikationshinweise
- WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:20000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- YWHAE (14-3-3 epsilon (YWHAE))
- Andere Bezeichnung
- YWHAE (YWHAE Produkte)
- Synonyme
- 14-3-3 antikoerper, 14-3-3 epsilon antikoerper, 14-3-3-e antikoerper, 14-3-3-epsilon antikoerper, 14-3-30epsilon antikoerper, 14-3-3EPSILON antikoerper, 14-3-3e antikoerper, 14-3-3omicron antikoerper, 1433epsilon antikoerper, 143E_DROME antikoerper, CG31196 antikoerper, CT24092 antikoerper, D14-3-3e antikoerper, D14-3-3epsilon antikoerper, Dmel\\CG31196 antikoerper, EK3-5 antikoerper, PAR-5 antikoerper, PAR5 antikoerper, Par-5 antikoerper, SR3-9 antikoerper, Su(Raf)3B antikoerper, anon-WO0172774.141 antikoerper, anon-WO02059370.52 antikoerper, d14-3-3epsilon antikoerper, eps antikoerper, l(3)j2B10 antikoerper, par-5 antikoerper, 14-3-3epsilon antikoerper, kcip-1 antikoerper, mdcr antikoerper, mds antikoerper, LOC581376 antikoerper, Ywhae antikoerper, ACYPI002517 antikoerper, YWHAE antikoerper, 14-3-3E antikoerper, KCIP-1 antikoerper, MDCR antikoerper, MDS antikoerper, AU019196 antikoerper, fe38c12 antikoerper, wu:fb48f06 antikoerper, wu:fe38c12 antikoerper, wu:fi22e10 antikoerper, ywhae antikoerper, zgc:55377 antikoerper, zgc:77062 antikoerper, CG31196 gene product from transcript CG31196-RD antikoerper, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon antikoerper, 14-3-3 epsilon antikoerper, 14-3-3 epsilon protein antikoerper, 14-3-3 protein epsilon antikoerper, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide antikoerper, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon antikoerper, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon S homeolog antikoerper, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide 1 antikoerper, 14-3-3epsilon antikoerper, ywhae antikoerper, LOC581376 antikoerper, Ywhae antikoerper, HCAG_04173 antikoerper, PTRG_02836 antikoerper, PTRG_04459 antikoerper, UREG_07864 antikoerper, YWHAE antikoerper, ywhae.S antikoerper, ywhae1 antikoerper
- Hintergrund
- 14 3 3 E antibody, 14 3 3 epsilon antibody, 14 3 3E antibody, 14-3-3 protein epsilon antibody, 14-3-3E antibody, 1433E_HUMAN antibody, Epididymis luminal protein 2 antibody, FLJ45465 antibody, FLJ53559 antibody, HEL2 antibody, KCIP 1 antibody, KCIP1 antibody, MDCR antibody, MDS antibody, Mitochondrial import stimulation factor L subunit antibody, Protein kinase C inhibitor protein1 antibody, Tyrosine 3 monooxygenase/tryptophan 5 monooxygenase activation protein, epsilon antibody, Tyrosine 3 monooxygenase/tryptophan 5 monooxygenase activation protein, epsilon polypeptide antibody, Tyrosine 3/tryptophan 5 monooxygenase activation protein epsilon polypeptide antibody, YWHAE antibody
- UniProt
- P62258
- Pathways
- Neurotrophin Signalübertragung, Myometrial Relaxation and Contraction, M Phase
-